Criteria | Number of studies fulfilling recommendation (n/N) | % |
---|---|---|
Competing alternatives clearly described | 18/30 | 60 |
Economic evaluation as primary objective | 22/30 | 73 |
Time horizon stated | 18/30 | 60 |
Perspective specified | 7/30 | 23 |
All important and relevant costs for each alternative identified | 9/30 | 30 |
All included cost measured appropriately | 14/30 | 47 |
All included costs valued appropriately | 12/30 | 40 |
Sources of cost data included | 24/30 | 80 |
Sources of outcome data included | 29/30 | 97 |
ICER/ BCR/NPV calculated and reported | 8/30 | 27 |
Cost discounted | 3/12 | 25 |
Outcome discounted | 3/12 | 25 |
Sensitivity analysis performed | 8/30 | 27 |
Generalisability of findings discussed | 4/30 | 13 |
Funding sources disclosed | 10/30 | 33 |